You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Details for Patent: 10,471,053


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,471,053
Title:Methods of treating Fabry patients having renal impairment
Abstract: Provided are methods for treatment of Fabry disease in patients having HEK assay amenable mutations in .alpha.-galactosidase A. Certain methods comprise administering migalastat or a salt thereof every other day, such as administering about 150 mg of migalastat hydrochloride every other day.
Inventor(s): Castelli; Jeff (New Hope, PA), Benjamin; Elfrida (Millstone Township, NJ)
Assignee: Amicus Therapeutics, Inc. (Cranbury, NJ)
Application Number:16/284,582
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,471,053
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,471,053: A Comprehensive Analysis

Introduction

Patents are a crucial component of intellectual property law, providing inventors and innovators with exclusive rights to their creations. To delve into the specifics of a patent, it is essential to analyze its scope and claims. This article will provide a detailed analysis of the scope and claims of United States Patent 10,471,053, using relevant resources and methodologies.

What is a Patent?

A patent is a form of intellectual property that gives its owner the legal right to exclude others from making, using, selling, and importing an invention for a certain period of time, usually 20 years from the date of filing. Patents are granted by the United States Patent and Trademark Office (USPTO) after a thorough examination process to ensure the invention meets the criteria of novelty, non-obviousness, and usefulness[4].

The Importance of Patent Claims

Patent claims are the heart of a patent, defining the scope of protection granted to the inventor. They specify what aspects of the invention are protected and distinguish the invention from prior art. Well-crafted claims are essential for enforcing patent rights and preventing infringement[3].

United States Patent 10,471,053: Overview

To analyze the scope and claims of United States Patent 10,471,053, one must first identify the patent's title, inventors, assignees, and the technology or field it pertains to. Here is a general outline:

  • Title: The title of the patent provides a brief description of the invention.
  • Inventors and Assignees: These are the individuals or entities credited with the invention and those who own the rights to the patent.
  • Field of Technology: This indicates the area or industry to which the invention applies.

Analyzing the Claims

Independent Claims

Independent claims stand alone and do not depend on other claims. They define the broadest scope of the invention and are crucial for determining the patent's overall protection.

  • Claim 1: Typically, Claim 1 is the broadest independent claim and sets the foundation for the rest of the claims.
  • Claim Structure: Claims are usually structured in a specific format, starting with a preamble that introduces the invention, followed by a transitional phrase ("comprising," "consisting of," etc.), and then the body of the claim that details the elements of the invention.

Dependent Claims

Dependent claims build upon independent claims and narrow down the scope by adding additional limitations or features.

  • Dependent Claim Structure: These claims start with a reference to the independent claim they depend on and then add further details or restrictions.

Claim Interpretation

Interpreting patent claims involves understanding the language used and the context in which the terms are defined. This often requires referring to the patent's specification and drawings to clarify any ambiguities.

Scope of Protection

The scope of protection is determined by the claims and is influenced by several factors:

  • Literal Infringement: This occurs when an accused product or process meets every element of a claim.
  • Doctrine of Equivalents: This allows for infringement to be found if an accused product or process performs substantially the same function in substantially the same way to achieve substantially the same result as the claimed invention[4].

Patent Landscape

The patent landscape includes all relevant patents and applications in the same field of technology. Analyzing this landscape helps in understanding the competitive environment and potential infringement risks.

  • Prior Art: This refers to existing knowledge and inventions in the public domain before the filing date of the patent. Prior art can affect the novelty and non-obviousness of the invention.
  • Patent Families: These are groups of related patents filed in different countries or jurisdictions, often covering the same invention.

Tools for Analysis

Several tools and resources are available for analyzing patents:

  • USPTO Public Search Facility: This provides access to patent and trademark information, including full-text searches and microfilm archives[4].
  • Global Dossier: This service allows users to view the file histories of related applications from participating IP Offices, including classification, citation data, and office actions[4].
  • Patent Examination Data System (PEDS): This system enables users to search, view, and download bibliographic data for publicly available patent applications[4].

Case Studies and Legal Precedents

Understanding the legal context and precedents is crucial for interpreting patent claims and scope. For example, the Supreme Court's decisions on patent enablement, such as in the case of Amgen Inc. v. Sanofi, highlight the importance of clear and concise descriptions in patent applications to meet the enablement requirement[2].

Practical Considerations

Drafting Claims

Drafting effective claims requires a deep understanding of the invention and the legal framework. Claims should be clear, concise, and broad enough to cover the invention but not so broad as to be invalid.

Enforcing Patents

Enforcing patents involves identifying potential infringers and taking legal action. This process can be complex and often requires expert legal advice.

Licensing and Collaboration

Patents can be licensed or used in collaborative agreements. Understanding the scope and claims is essential for negotiating these agreements.

Key Takeaways

  • Clear Claims: Well-drafted claims are essential for defining the scope of protection.
  • Contextual Understanding: Interpreting claims requires understanding the specification, drawings, and prior art.
  • Legal Framework: Familiarity with legal precedents and regulations is crucial for enforcing and defending patents.
  • Tools and Resources: Utilizing tools like the USPTO Public Search Facility and Global Dossier can aid in comprehensive patent analysis.

FAQs

What is the purpose of patent claims?

Patent claims define the scope of protection granted to the inventor, specifying what aspects of the invention are protected.

How are patent claims structured?

Claims are typically structured with a preamble, a transitional phrase, and the body of the claim detailing the elements of the invention.

What is the doctrine of equivalents in patent law?

The doctrine of equivalents allows for infringement to be found if an accused product or process performs substantially the same function in substantially the same way to achieve substantially the same result as the claimed invention.

What tools are available for analyzing patents?

Tools include the USPTO Public Search Facility, Global Dossier, and the Patent Examination Data System (PEDS).

Why is the enablement requirement important in patent law?

The enablement requirement ensures that a patent application describes the invention in such full, clear, concise, and exact terms as to enable any person skilled in the art to make and use the invention[2].

Sources Cited

  1. USPTO: "Patent Claims Research Dataset" - https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  2. Supreme Court: "Amgen Inc. v. Sanofi" - https://www.supremecourt.gov/opinions/22pdf/21-757_k5g1.pdf
  3. USPTO: "Search for patents" - https://www.uspto.gov/patents/search
  4. USPTO: "Patent and Trademark Resource Centers (PTRCs)" - https://www.uspto.gov/patents/search

Note: The specific details of United States Patent 10,471,053, such as its title, inventors, and claims, would need to be retrieved from the USPTO database or other patent search tools for a precise analysis.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,471,053

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amicus Therap Us GALAFOLD migalastat hydrochloride CAPSULE;ORAL 208623-001 Aug 10, 2018 RX Yes Yes ⤷  Try for Free ⤷  Try for Free THE TREATMENT OF FABRY PATIENTS ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.